Chemical | 28 May 2021
Mitsu Chem Plast reports Rs. 2.20 crore PAT in Q4FY21
The company has posted net profit of Rs.9.68 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.9.68 crores for the 12 months period ended March 31, 2021
The company has posted net loss of Rs. (28.35) crores for the 12 months period ended March 31, 2021
There was no casualty/injury reported due to fire and the company thanked the local administration, neighbouring industries and fire brigade for their timely support
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
The dividend will be paid June 14, 2021 to shareholders of record June 7, 2021
SK Capital plans to merge the two businesses to form a premier North American wood coatings company called Canlak Coatings
The industry is developing an e-learning module to help developing countries
Becoming Climate Neutral by 2050 is a huge task, not just for the energy-intensive sectors, but for the society at large
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
The process technology will be used for four Polypropylene (PP) lines, each producing 500 KTA, to be built in Erdos, Inner Mongolia, P.R. China
Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants
ISCC focuses on circular economy intending to ensure traceability of raw materials throughout the value chain and complies with the Renewable Energy Directive of the European Commission
The new capacity is expected to come online in the second half of 2022
Company plans to begin commercial operations in the latter half of 2023
Toyo-India will execute EPC work on a turnkey basis that includes Engineering, Procurement, Construction and Commissioning
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The company posted net profit of Rs.295.34 crores for FY v2020-21
It reported total income of Rs.339.28 crores during Fy 2020-21
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Subscribe to our newsletter & stay updated.
_195_291.jpg)
